Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160007/S060

Simplera system

Medtronic Minimed · Decision date Jun 12, 2026

FDA DECISIONP160007/S060

What did the FDA approve?

FDA records P160007/S060 as a supplement to PMA P160007, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jun 12, 2026.

FDA approval order statement

Approval for updating the sensor compressor dimensions in the Synergy Sensor (Simplera) assembly.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Clinical Chemistry
Decision date
Jun 12, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P160007/S060
Regulatory pathway
PMA supplement
Product code
MDS
Decision code
APPR
Decision date
Jun 12, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Sensor, glucose, invasive.

Product code
MDS
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P160007/S053 · Related supplement

    Guardian Connect system

  2. P160007/S054 · Related supplement

    Guardian Connect System

  3. P160007/S056 · Related supplement

    Guardian Connect System Simplera System

  4. P160007/S058 · Related supplement

    MiniMed Go app; Simplera sensor

  5. P160007/S060 received

    Application receipt date recorded by FDA.

  6. P160007/S062 · Related supplement

    Simplera and Simplera Sync

  7. P160007/S060 · FDA decision

    Real-Time Process

  8. P160007/S063 · Related supplement

    Simplera System; Simplera Sync

Timeline entries are records held by MedtechLedger for P160007. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160007

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic MinimedPMA supplementAug 25, 2025FDA
Simplera SystemP160007/S055
Medtronic MinimedPMA supplementSep 12, 2025FDA
Medtronic MinimedPMA supplementOct 9, 2025FDA
Medtronic MinimedPMA supplementOct 16, 2025FDA
Simplera SystemP160007/S057
Medtronic MinimedPMA supplementDec 5, 2025FDA
Simplera SystemP160007/S059
Medtronic MinimedPMA supplementDec 8, 2025FDA
Medtronic MinimedPMA supplementJan 23, 2026FDA
Medtronic MinimedPMA supplementMay 26, 2026FDA
Medtronic MinimedPMA supplementJul 21, 2026FDA

Explore the linked device profile

Other records with product code MDS

Product / regulatory recordCompanyPathwayDecision dateSource
Abbott Diabetes Care, Inc.PMA supplementSep 1, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Minimed

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
18000 Devonshire St., Northridge, CA, 91325

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records